{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:19:29Z","timestamp":1790752769656,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["DBI2013122856"],"award-info":[{"award-number":["DBI2013122856"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ijantimicag.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T20:00:18Z","timestamp":1501876818000},"page":"684-689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Minimum inhibitory concentration (MIC) distribution among wild-type strains of Legionella pneumophila identifies a subpopulation with reduced susceptibility to macrolides owing to efflux pump genes"],"prefix":"10.1016","volume":"50","author":[{"given":"Marine","family":"Vandewalle-Capo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Massip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislaine","family":"Descours","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9phine","family":"Charavit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Chastang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Alain","family":"Billy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Boisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Lina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Maurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Jarraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Ginevra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1128\/AAC.35.1.180","article-title":"In vitro activity of azithromycin against clinical isolates of Legionella species","volume":"35","author":"Edelstein","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jac\/41.2.289","article-title":"Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin\/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells","volume":"1","author":"Stout","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0020","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1086\/320526","article-title":"Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila","volume":"32","author":"Tan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0025","first-page":"407","article-title":"Factors influencing the case-fatality rate of Legionnaires' disease","volume":"13","author":"Dominguez","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0030","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1128\/JCM.19.6.723-729.1984","article-title":"Disk diffusion antimicrobial susceptibility testing of members of the family Legionellaceae including erythromycin-resistant variants of Legionella micdadei","volume":"19","author":"Dowling","year":"1984","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jac\/dkp173","article-title":"Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila","volume":"64","author":"Almahmoud","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0040","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1128\/AAC.44.10.2679-2683.2000","article-title":"Sequencing of the rpoB gene in Legionella pneumophila and characterization of mutations associated with rifampin resistance in the Legionellaceae","volume":"44","author":"Nielsen","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0045","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/jac\/dku196","article-title":"Isolation of ciprofloxacin-resistant Legionella pneumophila in a patient with severe pneumonia","volume":"69","author":"Bruin","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0050","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.ebiom.2015.07.018","article-title":"Hidden selection of bacterial resistance to fluoroquinolones in vivo: the case of Legionella pneumophila and humans","volume":"2","author":"Shadoud","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0055","series-title":"Antimicrobial susceptibility testing of Legionella pneumophila","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2016"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02188-16","article-title":"Ribosomal mutations conferring macrolide resistance in Legionella pneumophila","volume":"61","author":"Descours","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0065","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1183\/09031936.00076911","article-title":"Factors associated with hospital mortality in community-acquired legionellosis in France","volume":"39","author":"Chidiac","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jac\/dkg312","article-title":"European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria","volume":"52","author":"Kahlmeter","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0075","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/JCM.00432-16","article-title":"Evaluation of an optimal epidemiologic typing scheme for Legionella pneumophila with whole-genome sequence data using validation guidelines","volume":"54","author":"David","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0080","first-page":"1327","article-title":"Macrolide resistance in Legionella pneumophila: the role of LpeAB efflux pump","volume":"72","author":"Massip","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.diagmicrobio.2011.09.016","article-title":"Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates","volume":"72","author":"Bruin","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0090","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1128\/AAC.44.8.2176-2178.2000","article-title":"In vitro activities of gemifloxacin versus five quinolones and two macrolides against 271 Spanish isolates of Legionella pneumophila: influence of charcoal on susceptibility test results","volume":"44","author":"Garc\u00eda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0095","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/jac\/39.6.815","article-title":"Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila","volume":"39","author":"Onody","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0100","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1128\/AAC.01639-13","article-title":"Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1","volume":"58","author":"Mallegol","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.001_bib0105","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1128\/JB.183.19.5639-5644.2001","article-title":"Novel macrolide-specific ABC-type efflux transporter in Escherichia coli","volume":"183","author":"Saier","year":"2001","journal-title":"J Bacteriol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T07:03:26Z","timestamp":1602659006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917302935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0924857917302935"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.08.001","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimum inhibitory concentration (MIC) distribution among wild-type strains of Legionella pneumophila identifies a subpopulation with reduced susceptibility to macrolides owing to efflux pump genes","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}